Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma

Vaishampayan, 2003, Racial disparity in incidence patterns and outcome of kidney cancer, Urology, 62, 1012, 10.1016/j.urology.2003.07.010 Chow, 2013, Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics, Cancer, 119, 388, 10.1002/cncr.27690 Berndt, 2007, Disparities in treatment and outcome for renal cell cancer among older black and white patients, J Clin Oncol, 25, 3589, 10.1200/JCO.2006.10.0156 Krishnan, 2016, Intrinsic genomic differences between African American and white patients with clear cell renal cell carcinoma, JAMA Oncol, 2, 664, 10.1001/jamaoncol.2016.0005 Paulucci, 2017, Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma, Oncotarget, 8, 5196, 10.18632/oncotarget.14122 Nelson, 2022, Health inequity drives disease biology to create disparities in prostate cancer outcomes, J Clin Invest, 132, 10.1172/JCI155031 Chowdhury-Paulino, 2022, Racial disparities in prostate cancer among black men: epidemiology and outcomes, Prostate Cancer Prostat Dis, 25, 397, 10.1038/s41391-021-00451-z Schwartz, 2016, Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors, Cancer Med, 5, 200, 10.1002/cam4.578 Lipworth, 2016, Renal cell cancer histological subtype distribution differs by race and sex, BJU Int, 117, 260, 10.1111/bju.12950 Bilimoria, 2008, The national cancer data base: a powerful initiative to improve cancer care in the United States, Ann Surg Oncol, 15, 683, 10.1245/s10434-007-9747-3 Boffa, 2017, Using the national cancer database for outcomes research: a review, JAMA Oncol, 3, 1722, 10.1001/jamaoncol.2016.6905 Anon: 2016 FORDS: Facility Oncology Registry Data Standards.: 515. https://www.facs.org/media/r5rl5scw/fords-2016.pdf. Wong, 2021, Racial diversity among histology of renal cell carcinoma at an urban medical center, Clin Genitourin Cancer, 19, e166, 10.1016/j.clgc.2020.12.010 Olshan, 2013, Racial difference in histologic subtype of renal cell carcinoma, Cancer Med, 2, 744, 10.1002/cam4.110 Anastos, 2020, Black race may be associated with worse overall survival in renal cell carcinoma patients, Urol Oncol, 38, 938.e9, 10.1016/j.urolonc.2020.08.034 Jivanji, 2021, The association between race and 5-year survival in patients with clear cell renal cell carcinoma: a cohort study, Urology, 148, 185, 10.1016/j.urology.2020.10.055 Powell, 2019, Medical mistrust, racism, and delays in preventive health screening among African-American men, Behav Med, 45, 102, 10.1080/08964289.2019.1585327 Meagher, 2022, Disparities in cancer specific and overall survival outcomes in African Americans with renal cell carcinoma: analysis from the International Marker Consortium for Renal Cancer (INMARC), Urology, 163, 164, 10.1016/j.urology.2021.12.022 Sanchez, 2018, Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation, J Clin Oncol, 36, 3591, 10.1200/JCO.2018.79.2341 Alam, 2019, Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study, BJU Int, 123, 42, 10.1111/bju.14490 Marchioni, 2018, Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma, Cancer Epidemiol, 54, 112, 10.1016/j.canep.2018.04.006 Tripathi, 2006, Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma, Urology, 68, 296, 10.1016/j.urology.2006.02.036 Hsieh, 2018, Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision, J Pathol, 244, 525, 10.1002/path.5022 2013, Cancer genome atlas research network: comprehensive molecular characterization of clear cell renal cell carcinoma, Nature, 499, 43, 10.1038/nature12222 Linehan, 2016, Comprehensive molecular characterization of papillary renal-cell carcinoma, N Engl J Med, 374, 135, 10.1056/NEJMoa1505917 Choueiri, 2008, Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma, J Clin Oncol, 26, 127, 10.1200/JCO.2007.13.3223 Marchetti, 2021, The molecular characteristics of non-clear cell renal cell carcinoma: what's the story morning glory?, Int J Mol Sci, 22, 6237, 10.3390/ijms22126237 Singla, 2020, Progress toward precision medicine in frontline treatment of metastatic renal cell carcinoma, JAMA Oncol, 6, 25, 10.1001/jamaoncol.2019.4716